Highlights and Quick Summary
- Additional Paid In Capital for the quarter ending October 31, 2022 was $6.34 Million (a 21.27% increase compared to previous quarter)
- Year-over-year quarterly Additional Paid In Capital increased by Infinity%
- Annual Additional Paid In Capital for 2022 was $5.23 Million (a 140.03% increase from previous year)
- Annual Additional Paid In Capital for 2021 was $2.18 Million (a Infinity% increase from previous year)
- Annual Additional Paid In Capital for 2017 was $0 (a NaN% decrease from previous year)
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Additional Paid In Capital of BRIACELL THERAP
Most recent Additional Paid In Capitalof BCTX including historical data for past 10 years.Interactive Chart of Additional Paid In Capital of BRIACELL THERAP
BRIACELL THERAP Additional Paid In Capital for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $6.34 | $5.23 | $5.23 |
| 2021 | – | – | – | $2.18 | $2.18 |
| 2018 | – | $0.0 | $0.0 | $0.0 | – |
| 2017 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2016 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2015 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2014 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2013 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2012 | $0.0 | $0.0 | $0.91 | – | $0.0 |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology